drugset / Trial / NCT01949142

OTO-201 for the Treatment of Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement

NCT01949142

Phase 3 Completed 266 enrolled Otonomy, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to confirm the effectiveness, safety and tolerability of OTO-201 in the treatment of pediatric subjects with bilateral middle ear effusion who require tympanostomy tube placement.

Timeline

Start
2013-11
Primary completion
2014-05
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ciprofloxacin Small molecule 6 mg Intrathecal